Nath Bio-Genes (NATHBIOGEN)
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹155.06 |
| Market Cap | ₹295.09 Cr |
| P/E Ratio | 6.72 |
| ROCE | 6.96% |
| ROE | 8.13% |
| Dividend Yield | 1.29% |
| Profit Growth | -14.52% |
| Debt/Equity | 0.2 |
| Sales Growth | 15.18% |
| Promoter Holding | 45.6% |
| 52-Week Range | ₹126.15 — ₹204 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹304.36 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me look at Nath Bio-Genes with a value investor's discipline. The first thing that catches my eye is not earnings, but the balance sheet. The stock trades at ₹171 against book value of ₹341.05—a price-to-book of 0.50. That means I can buy a rupee of net assets for 50 paise. Graham would call that margin of safety, provided the assets are genuine and the business does not burn value. Debt is modest at 0.23 times equity, and promoter holding is 45.60%, which aligns them with public shareholders. A dividend yield of 1.33% confirms a small return even while waiting.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer